Pamela Freda is an Endocrinology/Metabolic physician affiliated with Columbia University. OpenAlex indexes 140 publications with 10,134 citations (h-index 54); ClinicalTrials.gov lists 13 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
180 Fort Washington Ave
New York, NY 100323735
Telephone
212-305-6238Registry record last updated 8 Jul 2007.
Clinical trials
- Adipose Tissue and Serum Inflammation in GH Deficiency
Sponsor: Columbia University
- Body Composition and Adipose Tissue in HIV
Sponsor: Columbia University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Chiesi USA, Inc.Program year20251 payment
- Amryt Pharma Holdings LtdProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
51.7%l-Thyroxine25.7%Levothyroxine Sodium81%Synthroid19%Part D<11 patientsGrowth Hormone Receptor Antagonist15.3%Somavert100%Part D<11 patients+ 2 more classes in this area
Nervous system
21.8%Ergot Derivative21.8%Cabergoline100%Part D<11 patientsSensory organs
15.7%Corticosteroid15.7%Hydrocortisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
9 NIH research awards on record, funded 1997–2026 per NIH RePORTER. The latest:
- Central Mediation of Growth Hormone Effects in Humans
Columbia University Health Sciences
FY2026$612,928R01DK133392 - Central Mediation of Growth Hormone Effects in Humans
Columbia University Health Sciences
FY2025$609,967R01DK133392 - Central Mediation of Growth Hormone Effects in Humans
Columbia University Health Sciences
FY2024$577,987R01DK133392
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Multidisciplinary management of acromegaly: A consensus
Reviews in Endocrine and Metabolic Disorders
2020 - Significant Benefits of <i>AIP</i> Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors
The Journal of Clinical Endocrinology & Metabolism
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Serge Przedborski, MD, PhD
Columbia University
Shonni Silverberg, MD
Columbia University
Mitchell Benson, MD
Columbia University
Andrew Lassman, MD
Columbia University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”